A. Patel

发表

Cutaneous Toxicities in Lung Cancer Patients on Immune Checkpoint Inhibitor Therapy.

M. Altan, Monika F. Keiser, A. Patel, 2021, Clinical lung cancer.

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity.

J. Heymach, A. Tsao, L. Byers, 2022, Cancer cell.

Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study

E. Sturgis, A. Lazar, R. Benjamin, 2022, Cancer.

Biologic therapies for checkpoint inhibitor-induced cutaneous toxicities: a single-institution study of 17 consecutively treated patients

Omar Pacha, A. Huen, Meghan M. Heberton, 2021, Supportive Care in Cancer.

Skin Reactions to Immune Checkpoint Inhibitors.

Omar Pacha, A. Patel, 2020, Advances in experimental medicine and biology.

Skin Reactions to Immune Checkpoint Inhibitors.

Omar Pacha, A. Patel, 2017, Advances in experimental medicine and biology.

Twelve cases of acneiform eruptions while on anti-CTLA4 therapy

N. Garg, A. Patel, Macartney Welborn, 2020, Supportive Care in Cancer.

Acneiform eruptions with combination targeted cancer therapy in colorectal cancer patients

C. Parseghian, M. Ibraheim, Rohit Gupta, 2022, Supportive Care in Cancer.

Erythema multiforme major in a patient with metastatic melanoma treated with nivolumab.

K. T. Nguyen, D. Ivan, K. Nelson, 2017, Dermatology online journal.

Autoimmune dermatologic toxicities from immune checkpoint blockade with anti‐PD‐1 antibody therapy: a report on bullous skin eruptions

M. Tetzlaff, P. Nagarajan, G. Jour, 2016, Journal of cutaneous pathology.

Reversion of methicillin-resistant Staphylococcus aureus skin infections to methicillin-susceptible isolates.

E. Simpson, J. Hanifin, E. Hill, 2013, JAMA dermatology.

Reversion ofMethicillin-Resistant Staphylococcus aureus Skin Infections toMethicillin-Susceptible Isolates

E. Simpson, J. Hanifin, E. Hill, 2013 .

Severe de novo pustular psoriasiform immune‐related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma

P. Nagarajan, Toshiyuki Yamamoto, P. Aung, 2021, Journal of cutaneous pathology.

Toxic Epidermal Necrolysis During Cotherapy with Ipilimumab and Nivolumab

A. Patel, Macartney Welborn, Shelby L Kubicki, 2018, Journal of Immunotherapy and Precision Oncology.

Characterization of Cutaneous Adverse Events Associated With PI3K Inhibitors in 11 Patients.

Omar Pacha, B. Freemyer, A. Patel, 2020, Journal of immunotherapy and precision oncology.

A retrospective chart review of management strategies for lichenoid eruptions associated with immune-checkpoint inhibitor therapy from a single institution.

Alexandria Brown, A. Patel, Wylie Masterson, 2022, Cancer treatment and research communications.

Immune Checkpoint Inhibitor Induced Vitiligo in Non-Melanoma Patients: Characterization and Management

Jo-Lin Lo, Hannah L Hanania, Monika F. Keiser, 2022 .

Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy: Incidence, management, and clinical benefit

J. McQuade, R. Amaria, H. Tawbi, 2021, Cancer.

Retrospective Chart Review of Cutaneous Adverse Events Associated with Tremelimumab in 17 Patients

N. Garg, A. Patel, Macartney Welborn, 2018, American Journal of Clinical Dermatology.

Acral retiform purpura

D. Ivan, A. Patel, Janet Y. Li, 2017, The Lancet.

Vandetanib photoinduced cutaneous toxicities.

S. Piha-Paul, V. Subbiah, H. Doan, 2019, Cutis.

Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case report

S. Piha-Paul, V. Subbiah, J. Curry, 2015, BMC Dermatology.

Clinicopathological correlation of acquired hypopigmentary disorders.

A. Kubba, R. Kubba, A. Patel, 2013, Indian journal of dermatology, venereology and leprology.

Postinflammatory hyperpigmentation: Review of pathogenesis, prevention, and treatment

A. Patel, 2014 .

Paraneoplastic pemphigus manifesting in a patient treated with pembrolizumab for urothelial carcinoma

P. Nagarajan, M. Campbell, J. Curry, 2021, JAAD case reports.

Clinicopathological correlation of acquired hyperpigmentary disorders.

A. Kubba, R. Kubba, A. Patel, 2013, Indian journal of dermatology, venereology and leprology.

Cutaneous Surgery Outcomes in Patients on Epidermal Growth Factor Receptor Inhibitors

Anisha B. Patel, V. Thomas, Kelly M Wilmas, 2021, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Racial Characteristics of Alopecia Areata in the United States.

A. Qureshi, E. Cho, S. Jung, 2020, Journal of the American Academy of Dermatology.

Poziotinib for Patients With HER2 Exon 20 Mutant Non–Small-Cell Lung Cancer: Results From a Phase II Trial

A. Tsao, D. Gibbons, F. Fossella, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cutaneous myoepithelioma of the foot

S. Tyring, Wesley J. Wu, Crystal E. Nwannunu, 2019, International journal of dermatology.

Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience

M. Suarez‐Almazor, K. Hess, T. Mendoza, 2018, Investigational New Drugs.

Management of Cutaneous Immunotherapy Toxicities.

M. Altan, A. Patel, 2021, Clinical lung cancer.

IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy

P. Hwu, M. Tetzlaff, A. Diab, 2019, Cancer Immunology Research.

A retrospective case series of 20 patients with immunotherapy-induced bullous pemphigoid with emphasis on management outcomes.

K. Nelson, Omar Pacha, A. Huen, 2022, Journal of the American Academy of Dermatology.

Mucocutaneous adverse events to immune checkpoint inhibitors

Alexandria Brown, F. Muhaj, A. Patel, 2023, Frontiers in Allergy.

Skin Reactions to Immune Checkpoint Inhibitors.

Omar Pacha, A. Patel, 2021, Advances in experimental medicine and biology.

Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding

M. Tetzlaff, P. Nagarajan, D. Ivan, 2016, Journal of cutaneous pathology.

Microcystic adnexal carcinoma with sebaceous differentiation: Three cases

M. Llamas-Velasco, C. Saus, A. Fernandez-Flores, 2018, Journal of cutaneous pathology.

Microcystic adnexal carcinoma ( MAC ) is a low-grade malignant tumor of the skin

M. Llamas-Velasco, C. Saus, A. Fernandez-Flores, 2018 .

A Case Report of a Cutaneous Mucinous Reaction Associated with Erlotinib Therapy Used in the Treatment of Metastatic Tonsillar Sinus Squamous Cell Carcinoma

B. Freemyer, A. Patel, T. Cabala, 2019, Journal of immunotherapy and precision oncology.

Unique Cutaneous Reaction to Second- and Third-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia

M. Mauro, A. Solomon, B. Ehst, 2015, Dermatology.

Application of least absolute shrinkage and selection operator logistic regression for the histopathological comparison of chondrodermatitis nodularis helicis and hyperplastic actinic keratosis

N. Klimas, S. Narala, A. Patel, 2020, Journal of cutaneous pathology.

Assessing dermatology resident confidence in caring for patients with skin of color

Rohit Gupta, H. Dao, M. Koshelev, 2021, Clinics in Dermatology.

Junctional melanocytic hyperplasia overlying benign fibrous papule: An under‐recognized variant of a common lesion

A. Patel, Kevin J. Krauland, 2020, Journal of cutaneous pathology.

A case of new-onset vitiligo in a patient on tofacitinib and brief review of paradoxical presentations with other novel targeted therapies.

Megan J Schlichte, Julie K. Nguyen, Reena P Jogi, 2020, Dermatology online journal.

Granulomatous dermatitis associated with ipilimumab therapy (ipilimumab associated granulomatous dermatitis)

N. Garg, P. Aung, A. Patel, 2018, Journal of cutaneous pathology.

Guidelines for implant placement to minimize impingement during activities of daily living after total hip arthroplasty.

P. Noble, S. Incavo, M. Thompson, 2010, The Journal of arthroplasty.

In Reply

M. Lacouture, P. O’Donnell, A. Patel, 2022, The oncologist.

Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin

M. Lacouture, J. Rosenberg, P. O’Donnell, 2022, The oncologist.

Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy

A. Ribas, M. Lacouture, M. Anadkat, 2021, Cancer discovery.

Regorafenib- associated panniculitis.

P. Aung, Anisha B. Patel, Ramya Chockalingam, 2016, Dermatology online journal.

Immune checkpoint inhibitor-induced cutaneous toxicities: A review of histopathologic and clinical features.

Julianna Martel, Hannah L Hanania, A. Patel, 2023, Human pathology.

Durvalumab-associated generalized morphea with overlapping vitiligo

J. Tayar, K. Woodman, Woo Cheal Cho, 2022, JAAD case reports.

Treatment recommendations for nail unit toxicities secondary to targeted cancer therapy based on collective experience and evidence based literature review.

A. Rubin, Megan L Wetzel, Hannah L Hanania, 2021, Journal of the American Academy of Dermatology.

Dermatomyositis associated with nivolumab therapy for melanoma: a case report and review of the literature.

Huifang Lu, I. Glitza, Brandy Drozd, 2020, Dermatology online journal.

Can quality keep up with quantity-Longitudinal trends in research output for the dermatology residency match.

D. Tahseen, J. Grant-Kels, Rohit Gupta, 2021, Clinics in dermatology.

M. Suarez‐Almazor, R. Amaria, S. Giordano, 2016 .

Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of TH 1 T-cells.

R. Amaria, C. Hudgens, M. Tetzlaff, 2023, Journal of cutaneous pathology.

Immune checkpoint inhibitor-induced vitiligo in cancer patients: characterization and management

Hannah L Hanania, A. Patel, Jonathan Lo, 2023, Archives of Dermatological Research.

Primary cutaneous follicle center lymphoma mimicking folliculitis.

S. Aneja, Ramya Chockalingam, A. Patel, 2018, Cutis.

Herpes vegetans as a sign of HIV infection.

T. Rosen, A. Patel, 2008, Dermatology online journal.

Treatment experience with encorafenib plus binimetinib for BRAF V600-mutant metastatic melanoma: management insights for clinical practice

H. Tawbi, A. Patel, Jocelyn Joseph, 2023, Melanoma research.

Tzanck smear for quick screening of transient myeloproliferative disorder in neonates with vesiculopapular eruptions

B. Kelly, M. Moody, A. Patel, 2015, International Journal of Dermatology.

Familial basaloid follicular hamartoma: a report of one family.

S. Hsu, Mandy S Harting, A. Patel, 2008, Dermatology online journal.

Tzanck smear for quick screening of transient myeloproliferative disorder in neonates with vesiculopapular eruptions

B. Kelly, M. Moody, A. Patel, 2015, International journal of dermatology.

Reversion of methicillin-resistant Staphylococcus aureus skin infections to methicillin-susceptible isolates.

E. Simpson, J. Hanifin, Emma E Hill, 2013, JAMA dermatology.

Pyoderma Gangrenosum Following Initiation of Immune Checkpoint Inhibitor Therapy

A. Patel, Macartney Welborn, Shelby L Kubicki, 2018, Journal of Immunotherapy and Precision Oncology.

Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis

J. V. Vanden Heuvel, Shuling Zhou, A. Patel, 2023, BioMed research international.

Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events.

J. McQuade, R. Jenq, A. Shah, 2024, Journal of the National Comprehensive Cancer Network : JNCCN.

Cutaneous toxicities of mitogen-activated protein kinase inhibitors in children and young adults with neurofibromatosis-1.

Z. Sadighi, A. Patel, Hannah L. Hanania, 2024, Journal of Neuro-Oncology.

A Retrospective Chart Review on Oral Retinoids as a Treatment for Epidermal Growth Factor Receptor Inhibitor and Mitogen-activated Protein Kinase Kinase Inhibitor Induced Acneiform Eruptions.

Naveen Garg, A. Patel, Elizabeth D Andrews, 2020, Journal of the American Academy of Dermatology.